about
Human immunodeficiency virus & cardiovascular riskInhibitor of DNA binding 4 (ID4) regulation of adipocyte differentiation and adipose tissue formation in micePolypharmacy in the HIV-infected older adult population.Heart and HAART: Two sides of the coin for HIV-associated cardiology issuesCarotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome.Update on HIV lipodystrophy.Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation.Dyslipidemia and cardiovascular disease risk factor management in HIV-1-infected subjects treated with HAART in the Spanish VACH cohort.Treatment options for lipodystrophy in HIV-positive patients.Cardiovascular disease risk factors among HIV-infected Nigerians receiving highly active antiretroviral therapy.Effects of angiotensin II type 1 receptor blocker and adiponectin on adipocyte dysfunction in stroke-prone spontaneously hypertensive rats.Prevalence of HIV-Associated Metabolic Abnormalities among Patients Taking First-Line Antiretroviral Therapy in Uganda.Lipoatrophy and lipohypertrophy are independently associated with hypertensionMitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapyIncreased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus diseaseNutrition and the HIV-associated lipodystrophy syndrome.Mechanisms Influencing Circadian Blood Pressure Patterns Among Individuals with HIV.Hypertension Is a Key Feature of the Metabolic Syndrome in Subjects Aging with HIVHigher Prevalence of Hypertension in HIV-1-Infected Patients on Combination Antiretroviral Therapy Is Associated With Changes in Body Composition and Prior Stavudine Exposure.Testicular histomorphologic and stereological alterations following short-term treatment with highly active antiretroviral drugs (HAART) in an experimental animal model.Lipoatrophic men 44 months after the diagnosis of lipoatrophy are less lipoatrophic but more hypertensive.Central/Peripheral fat mass ratio is associated with increased risk of hypertension in HIV-infected patients.Excess Clinical Comorbidity Among HIV-Infected Patients Accessing Primary Care in US Community Health Centers.
P2860
Q22241184-16279139-D89F-442A-AB22-A51C22411AEDQ28513950-E970274D-BE77-4E4C-84A5-18BABEC8B6B5Q34037407-F19E80A8-056F-4C4D-9D3F-6A523A7391D2Q34390565-140B0F8B-43D6-4720-AC46-34DB102EFF77Q35492436-996C0F9E-09DC-4656-B6DA-8E5DF01BFF20Q35833512-328306DB-0C05-4E80-87F6-BA628AAF0873Q36001196-FC27999D-42A6-4FB9-87BD-B648CB87012DQ36914867-1684DDD3-BB02-48E5-B5FD-BC7BA0426EDCQ37030842-BA7F9F0E-BE1C-467B-8B01-3CC1A99703B8Q37034973-AA37B222-65DE-45FB-9ABA-64ED3EB76D5CQ37113912-1CD8F5E3-8F09-4308-BD71-6F00C706BD08Q37157125-162B60B3-819C-48E5-9CCB-AF0ECEE72CD1Q37311726-9086106B-1AA4-474D-B6CF-5A93C212E515Q37344333-8CF5376D-6ADD-4F46-BE0C-737C6455DD5BQ37390635-D92D3845-486C-47DC-8F29-F4557BE65B88Q38061798-BF4E11D1-6B75-401F-BC77-14ADA0F89556Q38597452-09689075-794B-4CF3-9025-4AD4F53FA6A0Q38821848-7A872490-6681-474D-B1FD-439202A76906Q39796554-060CF305-BB5E-45F1-9427-7A1867D2229EQ42213076-3BD0E715-AF13-4244-8150-6909140EDEF2Q46596340-CEA9B919-465D-4DDC-BD4D-59CF590BEF9CQ47190529-D5D840DC-F737-435B-9EC3-9CF0FA533311Q47275628-38912DB1-8C2A-4193-8692-C820D26A369A
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Elevated blood pressure in subjects with lipodystrophy.
@en
Elevated blood pressure in subjects with lipodystrophy.
@nl
type
label
Elevated blood pressure in subjects with lipodystrophy.
@en
Elevated blood pressure in subjects with lipodystrophy.
@nl
prefLabel
Elevated blood pressure in subjects with lipodystrophy.
@en
Elevated blood pressure in subjects with lipodystrophy.
@nl
P2093
P1433
P1476
Elevated blood pressure in subjects with lipodystrophy.
@en
P2093
DeQuattro V
Sattler FR
P304
P356
10.1097/00002030-200110190-00013
P407
P577
2001-10-01T00:00:00Z